SCHEMBL3562816

SCHEMBL3562816

CN(C(=O)CN)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8295540 0.93 ALDH1A1 (0.50)
Hydrochloric Acid SCHEMBL19410087 0.89 ALDH1A1 (0.51)
SCHEMBL4145907 0.89 ALDH1A1 (0.56)
SCHEMBL4623391 0.86 PIK3CD (0.42)
SCHEMBL4623801 0.84 KMT2A (0.47)
Hydrochloric Acid SCHEMBL4877549 0.84 PIK3CD (0.41)
Hydrochloric Acid SCHEMBL4880426 0.82 POLB (0.48)
Hydrochloric Acid SCHEMBL3649783 0.80 DPP4 (0.50)
Hydrochloric Acid SCHEMBL15808506 0.78 SLC6A4 (0.43)
SCHEMBL14712982 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807686-B2 2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists N.V. ORGANON (NL) 2010-10-05 US disclosed
EP-2190838-A1 CANNABINOID RECEPTOR LIGANDS AstraZeneca AB (SE) 2010-06-02 EP disclosed
WO-2009024819-A1 CANNABINOID RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2009-02-26 WO disclosed
US-20080214553-A1 2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists MERCK SHARP & DOHME B.V. (NL) 2008-09-04 US disclosed
CN-1170823-C [ 5-chloro-6-phenyl-2- (4-trifluoromethylphenyl) -4-pyrimidinylamino ] acetamide derivatives, process for preparing the same, pharmaceutical compositions containing the same and intermediates for preparing the same 大日本制药株式会社 2004-10-13 CN disclosed
US-6620817-B1 Antiinflammatory, antiarthritic agents; autoimmune and rheumatic diseases DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2003-09-16 US disclosed
CN-1390207-A [ 5-chloro-6-phenyl-2- (4-trifluoromethylphenyl) -4-pyrimidinylamino ] acetamide derivatives, processes for preparing the same, pharmaceutical compositions containing the same and intermediates for these compounds DAINIPPON PHARMACEUTICAL CO (JP) 2003-01-08 CN disclosed
EP-1236721-A1 5-CHLORO-6-PHENYL-2-(4-TRIFLUOROMETHYLPHENYL)-4-PYRIMIDINYLAMINO]ACETAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATE OF THESE COMPOUNDS Dainippon Pharmaceutical Co., Ltd. (JP) 2002-09-04 EP disclosed